Effect of Selenium and Vitamin E on Iminodipropionitrile Induced Dyskinesia in Rats

References

• Al‐Deeb S., Al‐Moutairy K., Bruyn G. W., Tariq M. (1993) Attenuation by selenium of iminodipropionitrile induced neurotoxicity. Proceedings of Canadian College of Neuropsycopharmacology, Montreal. June, 1993, 26
   Google Scholar
• An G. J., Hong Z. S., Qui W. X. Effect of sodium selenite(ss) on action potentials of isolated guinea pig papillary muscle and pig purkinje fibres. Proceeding of 5th international symposium on selenium in biology and medicine, Nashville, TennesseeUSA, 1992; 86
   Google Scholar
• Backman E., Henrikson K. G. Effect of sodium selenite and vitamin E treatment in myotonic dystrophy. Journal of Internal Medicine 1990; 228: 577–581
   PubMed Web of Science ®Google Scholar
• Bangalore R., Hawthorn M., Triggle D. J. Iminodipropionitrile‐induced dyskinesia in mice: Striatal calcium channel changes and sensitivity to calcium channel antagonist. Journal of Neurochemistry 1991; 57: 550–555
   PubMed Web of Science ®Google Scholar
• Borek C., Ong A., Mason H., Donahue L., Blaglow J. E. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proceedings of National Academy of Science, USA 1986; 83: 1490–1494
   PubMed Web of Science ®Google Scholar
• Bryant R. W., Simon T. C., Bailey J. M. Role of glutathione peroxidase and hexose monophosphate shunt in the platelet lipoxygenase pathway. Journal of Biological Chemistry 1982; 257: 14937–14942
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Lohr J. B., Jeste D. V. Free radical and tardive dyskinesia. Trends in Neurosciences 1986; 9: 107–108
   Web of Science ®Google Scholar
• Cadet J. L., Braun T., Freed W. J. Clonidine and prazosin block the iminodipropionitrile (IDPN) induced spasmodic dyskinetic syndrome in mice. Pharmacology, Biochemistry and Behaviour 1987a; 26: 791–795
   PubMed Web of Science ®Google Scholar
• Cadet I. L., Braun T., Freed W. J. The dopamine D‐2 antagonist Ro22–1319 inhibits the persistent behavioural syndrome induced by iminodipropionitrile in mice. Experimental Neurology 1987b; 96: 594–650
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Taylor E., Freed W. J. The iminodipropionitrile induced dyskinetic syndrome in mice: Antagonism by the calcium channel. Antagonist nifedipine. Pharmacology, Biochemistry and Behaviour 1988; 29: 381–385
   PubMed Web of Science ®Google Scholar
• Clausen J., Gensen G. E., Nielsen S. A. Selenium in chronic neurological disease. Biology of Trace Element Research 1988; 15: 179–203
   PubMed Web of Science ®Google Scholar
• Csallany A. S., Su L. C. Selenium toxicity. Scientific Journal Series, Minnesota. 1984, Agricultural Experimental Station paper No.55108
   Google Scholar
• De la Cruz J. P., Garcia P. J., De la Cuesta F. S. Dipyridamole inhibits platelet aggregation induced by oxygen‐derived free radicals. Thrombosis Research 1992; 66: 277–285
   PubMed Web of Science ®Google Scholar
• Dexter D. T., Ward R. J., Wells F. R., Daniel S. E., Lees A. J., Peters T. J., Jenner P., Marsden C. D. a‐Tocopherol levels in brain are not altered in parkinson's disease. Annals of Neurology 1992; 32: 591–593
   PubMed Web of Science ®Google Scholar
• Diamond B. I., Reyes M. G., Borison R. A new animal model for Tourette syndrome. Giles de la Tourette Syndrome, A. J. Friedhoff, T. N. Chase. Raven Press, New York 1982; 221–225
   Google Scholar
• Diamond B. I., Sethi K., Borison R. C. Serotonin modulation of hyperkinesia and phasic neck dystonia induced by iminodipropionitrile (IDPN) in rats. Neurology 1986; 36(suppl 1)341
   Google Scholar
• Doutherty J. J., Hoekstra W. G. Vitamin E deficiency enhance Selenium toxicity. Proceedings of the Society for Experimental Biology and Medicine 1982; 169: 209–215
   PubMedGoogle Scholar
• Egan M. F., Thomas M. H., Gregory W. Treatment of tardive dyskinesia with vitamin E. American Journal of Psychiatry 1992; 149: 773–777
   PubMed Web of Science ®Google Scholar
• El‐kashef A. M., Ruskin P. E., Bacher N., Barrett D. Vitamin E in the treatment of tardive dyskinesia. American Journal of Psychiatry 1990; 147: 505–506
   PubMed Web of Science ®Google Scholar
• Fridovich I. Oxygen radicals, hydrogen peroxide and oxygen toxicity. Free Radicals in Biology and Medicine, W. A. Pryor. Academic Press, New York 1986; 239–257
   Google Scholar
• Fujita I., Nakatani E., Furaighi N., Sakuma S., Fujimoto Y. Potent inhibition of prostaglandin inactivation in rabbit gastric antral mucosal slices by selenium ions in‐vitro. Journal of Pharmacy and Pharmacology 1990; 42: 655–657
   PubMed Web of Science ®Google Scholar
• Gianutsos G., Sudzak P. D. Neurochemical effects of IDPN on the mouse brain. Neurotoxicology 1985; 6: 159–164
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J., Palmer R. M. J., Moncada S. Superoxide anion is involved in the breakdown of endothelium‐derived vascular relaxing factor. Nature 1986; 320: 454–456
   PubMed Web of Science ®Google Scholar
• Hall E. D., Pazara K. E., Braughler J. M. Effects of trialazid mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils. Stroke 1991; 22: 361–366
   PubMed Web of Science ®Google Scholar
• Handelman G. J., Epstein W. L., Macklin L. J., Van Kuijk J. G. M., Dratz E. A. Biopsy method for human adipose with Vitamin E and lipid measurements. Lipids 1988; 23: 598–604
   PubMed Web of Science ®Google Scholar
• Hoekstra W. G. Biochemical function of selenium and its relation to vitamin E. Federation Proceedings 1975; 34: 2083–2089
   PubMedGoogle Scholar
• Hovarth P. M., Ip C. Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Research 1983; 43: 5335–5341
   PubMed Web of Science ®Google Scholar
• Ip C. Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. Cancer Letters 1988; 39: 239–246
   PubMed Web of Science ®Google Scholar
• Jackson‐Lewis V., Przedborski S., Kostic V., Suber F., Fahn S., Cadet J. L. Partial attenuation of chronic fluphenazine induced changes in regional monoamine metabolism by D‐a‐Tocopherol in rat brain. Brain Research Bulletin 1991; 26: 251–258
   PubMed Web of Science ®Google Scholar
• Karpen C. W., Merola A. J., Trewyn R. W., Cornwell D. G., Panganmala R. V. Modulation of platelet thromboxane A2 and arterial prostacyclin be dietary vitamin E. Prostaglandins 1981; 22: 651–661
   PubMed Web of Science ®Google Scholar
• Lands W. E. M. Interaction of lipid hydroperoxides with eicosanoid biosynthesis. Journal of Free Radicals in Biology and Medicine 1985; 1: 97–101
   PubMedGoogle Scholar
• Lohr J. B., Cadet J. L., Lohr M. A., Jeste D. V., Wyatt R. J. Alpha tocopherol in tardive dyskinesia. Lancet 1987; 1: 913–914
   PubMed Web of Science ®Google Scholar
• Lohr J. B., Kuczenski R., Brache S., Moir M., Jeste D. V. Increased indices of free radical activity in the cerebrospinal fluid of patient with dyskinesia. Biological Psychiatry 1990; 28: 535–539
   PubMed Web of Science ®Google Scholar
• Medina D., Morrison D. G. Current ideas on selenium as a chemoprotective agents. Pathological and Immunopathological Research 1988; 7: 187–199
   PubMedGoogle Scholar
• Meydani M., Macauley J. B., Blumberg J. B. Effect of dietary vitamin E and selenium on susceptability of brain regions to lipid peroxidation. Lipids 1988; 23: 405–409
   PubMed Web of Science ®Google Scholar
• Meydani M., Meydani S. N., Jeffrey B. B. Modulation by dietary vitamin E and selenium of clotting whole blood thromboxane A2 and aortic prostacyclin synthesis in rats. Journal of Nutritional Biochemistry 1993; 4: 322–326
   Web of Science ®Google Scholar
• Mitchell J. D., Jackson M. J., Pentland B. Indices of free radical activity in the cerebrospinal fluid in motor neuron disease. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50: 919–922
   PubMed Web of Science ®Google Scholar
• Ogawa N., Haba K., Asanuma M., Mori A. Long‐lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile. Brain Research 1991; 556: 271–179
   PubMed Web of Science ®Google Scholar
• Pall H. S., Williams A. C., Blake D. R., Lunec J. Evidence of enhanced lipid peroxidation in cerebrospinal fluid of patients taking phenothiazine. Lancet 1987; 2: 596–599
   PubMed Web of Science ®Google Scholar
• Panganmala R. V., Cornwell D. G. Role of vitamin E and selenium on arachidonic acid oxidation. Annals of the New York Academy of Sciences 1980; 393: 370–391
   Google Scholar
• Saunders R. D., Dugan L. L., Demediuk P., Means E. D., Horrocks L. A., Anderson D. K. Effect of methyl prednisolone and the combination of a tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. Journal of Neurochemistry 1987; 49: 24–31
   PubMed Web of Science ®Google Scholar
• Schneider J. S. Role of basal ganglia in a chemically induced dyskinesia in rat. Experimental Neurology 1984; 84: 524–532
   PubMed Web of Science ®Google Scholar
• Tien M., Aust S. V. Comparative aspect of several model lipid peroxidation system. Lipid peroxides in Biology and Medicine, K. Yagi. Academic Press, New York 1982; 23–39
   Google Scholar